Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications

Pharmacological management of metabolic syndrome and its lipid complications

Obesity epidemic has been spread all over the world in the past few decades and has caused a major public health concern due to its increasing global prevalence. Obese individuals are at higher risks of developing dyslipidemic characteristics resulting in increased triglyceride and LDL-cholesterol content and reduced HDL-cholesterol levels. This disorder has profound implications as afflicted i...

LIPID DISORDERS The review of medicines for treating lipid disorders

Lipid Disorders

Multiple epidemiologic studies have demonstrated the relationship between cardiovascular mortality and elevated plasma cholesterol levels. Lipid-lowering therapy, particularly with hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins), has demonstrated survival benefit in both primary prevention (patients without evidence of atherosclerotic cardiovascular disease [ASCVD]) an...

How To Treat - Lipid Disorders

Therapy of lipid disorders.